Retired
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The limitations have been pointed out, none of the recommendations and changes have been codified into the rules. Hence my political activism to actually make changes.
On a similar note I advocate for Congres to address the deficiencies and loopholes in the system that allow "the shorts" to run rampant legally.
Actually precisely the opposite supply/ demand and LIQUIDITY are always in play with price discovery.
I'm just adding factual context to your FUD, since either you lack the knowledge or have a motive to spin to the negative 24/7.
Nice try at instilling "doubt" versus the normal "uncertainty" theme, but the clinicaltrials.gov site only requires an update every 12 months and companies big and small have been criticized for not providing more timely updates to the service.
I highly recommend you read the disclosures provided by the FDA on the limitations of their site.
Last update to the locations section was "2021-04-03"
https://clinicaltrials.gov/study/NCT04314934?term=attention%20ad&rank=1&tab=history
Adam F has wide latitude as an opinion writer and freedom of speech. He's full of 1/2 truths and lies veiled as opinions.
Kind of like many of the post here by team FUD that also feed off of the inherent uncertainty of biotech investing.
Way too early to make a call, but upside momentum appears intact as the 200 SMA day level at $9.44 is challenged.
Indeed, I'm most curious to see if above average volume will continue.
Volume, as a basic indicator tells me others participated, it needs not be me or you. ;)
I did participate unexpectedly and flipped a 1 day hold on the Oct $14 Calls I bought on a fluke probing the option market's quotes and got filled. That was one of my first "sells" of $AVXL in years.
With your opinion, I'm sure you did not actively participate in today's rally, while others who felt the release of the actual numbers and a confirmation of the plans from the CEO was material enough to initiate buy side trades.
I strongly doubt the citizens of ihub have the cash to produce this type of volume or price move.
The release of the company's financials is considered a material event which contains substantial new news.
Imbalances of supply and demand and the resultant price movement are how markets are made. Every price move is NOT a freaking manipulation.....
Tomorrow is a wild card, demand continues or it doesn't and a retracement occurs.
I consider the $10.17 print on 6/9 as "out of range" noise and drew the line across the lower tops and think a break out occurred at ~$8.30
Broke the apex of the triangle to the upside.
And if backed up with a market cap valuation adjustment to the upside, this could get really interesting.
Of course this could be another top in the formation, but as you said, t's gotta give.
Gee wiz, maybe the WGT crowd got larger after that conference call and earnings report.
The people who follow my post know what they own, and how it's financed. So your comment does not represent my followers.
überraschen, “surprise, astonish, astound, overtake, and take aback.” is the plan indeed.
Soumit Roy has a 26% success rate. Well for context. That's not too bad when one covers a sector with 95% failure rate.
FUD, only simpletons don't understand the need for microcaps to have open lines of financing.
So true. In may ways being a good broker was reeling in your clients excitement and setting expectations accordingly and adjust their position size based on levels of confidence and client risk tolerance.
But, every biotech needs a WGT segment or none of them would get funded.
When investing is done correctly and "safely" within one risk tolerance and financial means, IMO, it's required to have some speculation in the portfolio.
FWIW, the data regarding the effect of a "drug holiday" was with PDD trial...not Rett.
https://www.anavex.com/post/anavex-2-73-blarcamesine-shows-clinical-benefit-in-long-term-48week-phase-2-extension-study-in-pdd
It would honestly take very little for $AVXL to shake off it's OTC origin story and that's delivering on milestones. Trust me I'm no Dr.M superfan but will give him a fair shake.
I'm of the opinion simply reporting out on Rett and a NDA timeline will bring in some buyers and firm up $AVXL's market cap. In addition a PD trial start by the MJFF supported "Shake it Up Foundation" could do the same. It's my "hope" this can break away the sympathetic trading pattern $AVXL has with the $XBI.
I'm agreeing, but I'm a d/ck? Every daily move up and down is not always due to come cabalish action as your narrative claims. That's my beef. Yes there are many market players and participants, but it's not all collusion.
That's all stuff I know already and hasn't changed much, I'm thinking a bit deeper into the mechanics and if use of the crossing session and it's guaranteed liquidity is an advantage "they" leverage when so few market centers process the volume?
It's a trend and pattern over time analysis, not simply a proportion question and this is different from the MOC order type available to some.
He's one of the people I hope see's it. But, his context of the system may be as old as mine. The trades and system gaming is based upon the recent changes to trading and systems.
It's probably nothing, but when I don't know how I ask. ;)
Now given the fact the payment for order flow has changed market functioning and reduced the number of market centers is there gaming of the system going on?
OMG I'm sounding more and more like "Sparky" every year. LOL!
If this makes any since to anyone, pls advise. ;)
The pattern I'm curious about is that for $AVXL there is consistently a bulk of the daily share volume traded (buy and a sell) conducted precisely at 16:00:00. Access to this negotiated price type of transaction is part of the feature set of trading as a NASDAQ listed stock.
Sometimes it's good, sometimes it's bad. Regardless it allows for a substantial amount of shares to be crossed at a guaranteed price. This type of liquidity has value to various market participants. My conspiracy hunch is because of way orders get processed in todays market, at a limited number of "market centers", there are inside departments and divisions that could take advantage of such value in combination with the payment for order flow model.
Am I crazy? Could there folks be the dastardly manipulative cabals? Sure why not. See it all on a Netflix special someday. LOL
The pattern I'm curious about is that for $AVXL there is consistently a bulk of the daily share volume traded (buy and a sell) conducted precisely at 16:00:00. Access to this negotiated price type of transaction is part of the feature set of trading as a NASDAQ listed stock.
Sometimes it's good, sometimes it's bad. Regardless it allows for a substantial amount of shares to be crossed at a guaranteed price. This type of liquidity has value to various market participants. My conspiracy hunch is because of way orders get processed in todays market, at a limited number of "market centers", there are inside departments and divisions that could take advantage of such value in combination with the payment for order flow model.
Am I crazy? Could there folks be the dastardly manipulative cabals? Sure why not. See it all on a Netflix special someday. LOL
$AVXL volume is poor and to me it trades "funky" via the crossing session.
Rumor has it, It's all the cabal's and their computers gaming the system. I've give that hunch a, you're probably right guess. LOL!
On a related tangent, I'm curious if there has been a good explanation of "why" there is so much crossing session volume for $AVXL?
True, but maybe I want attention too.
Now where's the fun in that?!?
I'm here for the entertainment. Next time try not replying. LOL
Very interesting that you asked that question, and that is precisely the reason why the rule was created in the first place.
Nobody is supposed to apply any importance or weight to those transactions conducted under that plan in the first place. And to eliminate any confusion that is the 375 share purchases from the very early days.
The most recent insider share purchase was specifically done via rule 144. Specifics of the transactions do matter.
I use insider ownership and insider trades as a tertiary indicator.
My comment then really wasn't for you then was it. It was for anyone who reads the thread.
Learning is a choice....
I just explained the how, you'll have to ask the executive, Dr. Missing the reasons for his decision on amounts and timing.
I believe these topics have been covered before.